Prognostic value of breast cancer aromatase

Allan Lipton; Richard J. Santen; Steven J. Santner; Harold A. Harvey; Sherry I. Sanders; Yvonne L. Matthews

doi:10.1002/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-%23

Prognostic value of breast cancer aromatase

Allan Lipton
, Richard J. Santen
, Steven J. Santner
, Harold A. Harvey
, Sherry I. Sanders
, Yvonne L. Matthews

Research output: Contribution to journal › Article › peer-review

73 Scopus citations

Abstract

The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease‐free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease‐free interval or survival. Cancer 1992; 70:1951‐1955.

Original language	English (US)
Pages (from-to)	1951-1955
Number of pages	5
Journal	Cancer
Volume	70
Issue number	7
DOIs	https://doi.org/10.1002/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-%23
State	Published - Oct 1 1992

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

10.1002/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-%23

Cite this

@article{d704e5317e0348ff8b2a913200f92bc6,

title = "Prognostic value of breast cancer aromatase",

abstract = "The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease‐free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69\%) tumors. There was no relationship between aromatase activity and disease‐free interval or survival. Cancer 1992; 70:1951‐1955.",

author = "Allan Lipton and Santen, \{Richard J.\} and Santner, \{Steven J.\} and Harvey, \{Harold A.\} and Sanders, \{Sherry I.\} and Matthews, \{Yvonne L.\}",

year = "1992",

month = oct,

day = "1",

doi = "10.1002/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-\%23",

language = "English (US)",

volume = "70",

pages = "1951--1955",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Prognostic value of breast cancer aromatase

AU - Lipton, Allan

AU - Santen, Richard J.

AU - Santner, Steven J.

AU - Harvey, Harold A.

AU - Sanders, Sherry I.

AU - Matthews, Yvonne L.

PY - 1992/10/1

Y1 - 1992/10/1

N2 - The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease‐free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease‐free interval or survival. Cancer 1992; 70:1951‐1955.

AB - The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease‐free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease‐free interval or survival. Cancer 1992; 70:1951‐1955.

UR - https://www.scopus.com/pages/publications/0026746314

UR - https://www.scopus.com/pages/publications/0026746314#tab=citedBy

U2 - 10.1002/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-%23

DO - 10.1002/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-%23

M3 - Article

C2 - 1525771

AN - SCOPUS:0026746314

SN - 0008-543X

VL - 70

SP - 1951

EP - 1955

JO - Cancer

JF - Cancer

IS - 7

ER -

Prognostic value of breast cancer aromatase

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this